Key result
Leadless pacemakers show a ~7% bloodstream infection rate with no documented device infections.
Why the study?
The study aimed to describe postimplantation bloodstream infections among first-time leadless pacemaker recipients.
Cohort (n=309)
No
In a single-center cohort of 309 leadless pacemaker recipients, no device infections were documented despite 27 episodes of bloodstream infection in 22 patients.
Answers are grounded in this paper and cite their sources.
May support leadless pacemaker preference in infection-prone patients; leaves open prospective validation of device-related infection rates.
We described postimplantation bloodstream infections among 309 first-time leadless pacemaker recipients in a single-center retrospective cohort. Twenty-two patients experienced 27 bloodstream infection episodes. Diagnostic evaluation varied by organism and suspected source. No leadless pacemaker infection was documented, although the small sample and nonuniform evaluation preclude precise risk estimation.
No takes yet. Share an insight, caveat, or question.
Johnson et al. (2026) conducted a cohort in Bloodstream infections in leadless pacemaker recipients (n=309). Leadless pacemaker implantation was evaluated on Postimplantation bloodstream infection and leadless pacemaker infection. First-time leadless pacemaker recipients had a 7.1% (22/309) rate of bloodstream infection (27 episodes), with 0% documented device infections.
Synapse has enriched 10 related papers. Consider them for comparative context: